Literature DB >> 12362242

The mucin-like macroglycopeptide region of glycoprotein Ibalpha is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding.

Chester Q Li1, Jing-fei Dong, José A López.   

Abstract

A dominant feature of the structure of platelet glycoprotein (GP) Ibalpha, the von Willebrand factor (VWF)-binding subunit to the GP Ib-IX-V complex, is the presence of an elongated, heavily glycosylated mucin-like stalk between the plasma membrane and the N-terminal 45-kDa ligand-binding domain. Here, we investigated the function of that region by expressing a mutant lacking residues 318-452 as part of a recombinant GP Ib-IX complex. We studied the VWF-binding function of this mutant under both static conditions and flow. The mutant GP Ibalpha was expressed normally on the surface of CHO bIX cells (stably expressing GP Ibbeta and GP IX) and the proper conformation of the ligand-binding region was verified by the normal binding of 5 conformation-sensitive monoclonal antibodies. Under static conditions, cells expressing mutant GP Ibalpha bound VWF (binding induced by either botrocetin or ristocetin) in a manner indistinguishable from cells expressing wild-type GP Ibalpha. We also evaluated the ability of the mutant to mediate cell adhesion to immobilized VWF in the presence of fluid shear stress (at 2 and 10 dyn/cm(2)). When the mutant-expressing cells were incubated with immobilized VWF for 1 min before being exposed to shear, they rolled on the VWF surface in a manner similar to wild-type cells. However, if the cells were not first allowed to settle on the surface before the application of shear stress, the mutant GP Ibalpha was unable to capture the cells onto the VWF surface from the fluid stream, an indication that steric hindrance from other cell surface molecules may prevent access of the GP Ibalpha ligand-binding site to the surface-immobilized VWF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12362242

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Influence of Brownian motion on blood platelet flow behavior and adhesive dynamics near a planar wall.

Authors:  Nipa A Mody; Michael R King
Journal:  Langmuir       Date:  2007-04-07       Impact factor: 3.882

2.  Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells.

Authors:  Sarah L King; Hiren J Joshi; Katrine T Schjoldager; Adnan Halim; Thomas D Madsen; Morten H Dziegiel; Anders Woetmann; Sergey Y Vakhrushev; Hans H Wandall
Journal:  Blood Adv       Date:  2017-02-23

3.  Unaccompanied mechanosensory domain mediates low expression of glycoprotein Ibα: implications for Bernard-Soulier syndrome.

Authors:  Yue Tao; Chi Gan; Xiaoqin Zhang; Lanbo Liu; Philip M Zakas; Christopher B Doering; Xi Mo; Renhao Li
Journal:  J Thromb Haemost       Date:  2019-12-22       Impact factor: 5.824

4.  Deciphering the Roles of N-Glycans on Collagen-Platelet Interactions.

Authors:  Christian Toonstra; Yingwei Hu; Hui Zhang
Journal:  J Proteome Res       Date:  2019-05-15       Impact factor: 4.466

5.  The membrane-proximal intermolecular disulfide bonds in glycoprotein Ib influence receptor binding to von Willebrand factor.

Authors:  X Mo; S-Z Luo; A D Munday; W Sun; M C Berndt; J A López; J-F Dong; R Li
Journal:  J Thromb Haemost       Date:  2008-07-19       Impact factor: 5.824

6.  Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP.

Authors:  Bojing Shao; Christopher Hoover; Huiping Shi; Yuji Kondo; Robert H Lee; Junmei Chen; Xindi Shan; Jianhua Song; J Michael McDaniel; Meixiang Zhou; Samuel McGee; Karen Vanhoorelbeke; Wolfgang Bergmeier; José A López; James N George; Lijun Xia
Journal:  Blood       Date:  2022-04-21       Impact factor: 22.113

Review 7.  Structure-function of platelet glycoprotein Ib-IX.

Authors:  M Edward Quach; Renhao Li
Journal:  J Thromb Haemost       Date:  2020-08-24       Impact factor: 16.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.